Clinical Trial Update: TCR Alpha/Beta and CD19-deplete Haplo-HSCT [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating TCR alpha/beta and CD19-depleted haploidentical hematopoietic stem cell transplantation in pediatric patients with hematolog…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• TCR alpha/beta and CD19-depleted haploidentical HSCT

Snippet

Sponsor: University of Colorado, Denver | Conditions: Pediatric Patients, Hematologic Malignancy | Phase 2 | Status: WITHDRAWN